CME/CE
- Collaborating to Improve Care for Hemophilia: Managed Care Strategies for the Evolving Treatment Paradigm
- Cases in Cost Optimization and Care Coordination for Managed Care and Specialty Pharmacy
- Cost Optimization and Care Coordination for Managed Care and Specialty Pharmacy
- Hemophilia Clinical Updates and Cost Management Solutions
Loading. Please Wait...
LIVE VIRTUAL SYMPOSIUM
Friday, April 16 | 9:00am-10:30am ET
Collaborating to Improve Care for Hemophilia: Managed Care Strategies for the Evolving Treatment Paradigm – Certified for Nurses, Pharmacists, and Physicians
Up to 1.5 credit hours available
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…
- Describe recent insights into the safety, efficacy, and unique attributes of recently approved and emerging hemophilia treatment options.
- Assess the integration of the evolving treatment paradigm within the current hemophilia treatment algorithm.
- Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences.
- Apply processes for managed care and specialty pharmacy professionals to improve communication and collaboration with HTCs.
Expert Faculty
James T. Kenney, RPh, MBA
Founder and President
JT Kenney, LLC
Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center
Vanita K. Pindolia, PharmD, BCPS
Vice President, Ambulatory Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health Alliance Plan of Michigan
For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/amcp2021/
Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by independent educational grants from Novo Nordisk and uniQure biopharma B.V.
ManagedCareHemo.com Presents Cases in Cost Optimization and Care Coordination for Managed Care and Specialty Pharmacy – Certified for Nurses, Pharmacists, and Physicians
Up to 1.0 credit hour available
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…
- Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
- Review alignment of recently approved therapies in the current hemophilia treatment algorithm
- Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
- Apply processes for managed care and specialty pharmacy professionals to improve communication and collaboration with HTCs
Expert Faculty
James T. Kenney, RPh, MBA
Founder and President
JT Kenney, LLC
Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center
John Fox, MD, MHA
Chief Boundary Spanner
Foxworthy Healthcare Consulting, LLC
For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/costoptimization/
Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
This activity is supported by independent educational grants from BioMarin, CSL Behring, Sanofi Genzyme, Takeda, and uniQure, Inc.
ManagedCareHemo.com Presents a Clinical Primer: Cost Optimization and Care Coordination for Managed Care and Specialty Pharmacy – Certified for Nurses, Pharmacists, and Physicians
Up to 1.0 credit hour available
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…
- Describe recent insights into the safety, efficacy, and unique attributes of recently approved and emerging hemophilia treatment options.
- Review alignment of recently approved therapies in the current hemophilia treatment algorithm.
- Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences.
- Apply processes for managed care and specialty pharmacy professionals to improve communication and collaboration with HTCs
Expert Faculty
James T. Kenney, RPh, MBA
Founder and President
JT Kenney, LLC
Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center
John Fox, MD, MHA
Chief Boundary Spanner
Foxworthy Healthcare Consulting, LLC
For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/clinicalprimer/
Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
This activity is supported by independent educational grants from BioMarin, CSL Behring, Sanofi Genzyme, Takeda, and uniQure, Inc.
Hemophilia Clinical Updates and Cost Management Solutions – Certified for Nurses, Pharmacists, and Physicians
Up to 1.25 credit hour available
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…
- Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
- Review alignment of recently approved therapies in the current hemophilia treatment algorithm
- Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
- Apply processes for managed care and specialty pharmacy professionals to improve communications and collaborations with HTCs
Expert Faculty
Shannon Carpenter, MD, MS
Professor of Pediatrics, UMKC School of Medicine Hematology/Oncology, Director Kansas City Regional Hemophilia Treatment Center
Director, Anticoagulation Management Program
Children’s Mercy Hospital
Jeffrey Dunn, PharmD, MBA
Vice President, Clinical Strategy and Programs and Industry Relations
Magellan Rx Management
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC
For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/clinical-updates-cost-management-solutions-ce/
Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Shire, now part of Takeda.
